Robert Flisiak
Publications by Year
Research Areas
Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, COVID-19 Clinical Research Studies, HIV/AIDS drug development and treatment
Most-Cited Works
- → Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection(2011)2,373 cited
- → Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study(2016)2,024 cited
- → Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B(2005)1,515 cited
- → Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B(2008)1,173 cited
- → Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3(2014)796 cited
- → Advancing the global public health agenda for NAFLD: a consensus statement(2021)709 cited
- → Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study(2022)627 cited
- → Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B(2010)461 cited
- → Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection(2018)430 cited
- → A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel(2011)406 cited